Treatment of Malignant Melanoma With GPA-TriMAR-T Cell Therapy
Condition(s):Malignant MelanomaLast Updated:December 6, 2019Unknown status
Hide Studies Not Open or Pending
Condition(s):Malignant MelanomaLast Updated:December 6, 2019Unknown status
Condition(s):Granulomatosis With Polyangiitis (GPA); Microscopic Polyangiitis (MPA)Last Updated:May 26, 2022Terminated
Condition(s):Granulomatosis With PolyangiitisLast Updated:July 9, 2021Recruiting
Condition(s):Granulomatosis With Polyangiitis; Microscopic Polyangiitis; Wegener’sLast Updated:July 12, 2022Completed
Condition(s):Granulomatosis With PolyangiitisLast Updated:April 15, 2021Completed
Condition(s):Granulomatosis With PolyangiitisLast Updated:August 25, 2020Withdrawn
Condition(s):Granulomatosis With Polyangiitis (GPA); Microscopic Polyangiitis (MPA)Last Updated:August 25, 2022Completed
Condition(s):Granulomatosis With Polyangiitis (Wegener’s Granulomatosis)Last Updated:March 22, 2018Terminated
Condition(s):Wegener’s GranulomatosisLast Updated:April 21, 2015Completed
Condition(s):Granulomatosis With Polyangiitis (Wegener’s); Granulomatosis With Polyangiitis; Wegener’s Granulomatosis; ANCA-Associated VasculitisLast Updated:August 14, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.